These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8441037)

  • 21. Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results.
    Paganelli G; Bartolomei M; Ferrari M; Cremonesi M; Broggi G; Maira G; Sturiale C; Grana C; Prisco G; Gatti M; Caliceti P; Chinol M
    Cancer Biother Radiopharm; 2001 Jun; 16(3):227-35. PubMed ID: 11471487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (211)At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-Lysine as multicarriers.
    Lindegren S; Karlsson B; Jacobsson L; Andersson H; Hultborn R; Skarnemark G
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3873S-9S. PubMed ID: 14506185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization.
    Shoup TM; Fischman AJ; Jaywook S; Babich JW; Strauss HW; Elmaleh DR
    J Nucl Med; 1994 Oct; 35(10):1685-90. PubMed ID: 7931672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin.
    Paganelli G; Stella M; Zito F; Magnani P; De Nardi P; Mangili F; Baratti D; Veglia F; Di Carlo V; Siccardi AG
    J Nucl Med; 1994 Dec; 35(12):1970-5. PubMed ID: 7989979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
    Paganelli G; Magnani P; Zito F; Villa E; Sudati F; Lopalco L; Rossetti C; Malcovati M; Chiolerio F; Seccamani E
    Cancer Res; 1991 Nov; 51(21):5960-6. PubMed ID: 1933860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorption.
    Hartmann C; Bloedow DC; Dienhart DG; Kasliwal R; Johnson TK; Gonzalez R; Bunn PA
    J Pharmacokinet Biopharm; 1991 Aug; 19(4):385-403. PubMed ID: 1920086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
    Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
    J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?
    Aarts F; Hendriks T; Eek A; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Biother Radiopharm; 2009 Feb; 24(1):29-34. PubMed ID: 19243245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with (90)Y-biotin?
    Grana C; Bartolomei M; Handkiewicz D; Rocca P; Bodei L; Colombo N; Chinol M; Mangioni C; Malavasi F; Paganelli G
    Gynecol Oncol; 2004 Jun; 93(3):691-8. PubMed ID: 15196866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid blood clearance of biotinylated IgG after infusion of avidin.
    Sinitsyn VV; Mamontova AG; Checkneva YY; Shnyra AA; Domogatsky SP
    J Nucl Med; 1989 Jan; 30(1):66-9. PubMed ID: 2911044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-step tumor pre-targeting in lung cancer immunoscintigraphy.
    Dosio F; Magnani P; Paganelli G; Samuel A; Chiesa G; Fazio F
    J Nucl Biol Med (1991); 1993 Dec; 37(4):228-32. PubMed ID: 8172965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of avidin for speedy clearance of biotinylated immunoglobulins from the blood flow].
    Sinitsyn VV; Mamontova AG; Chekneva EE; Shnyra AA; Domogatskiĭ SP
    Biull Eksp Biol Med; 1990 Jun; 109(6):567-9. PubMed ID: 2397294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility of a novel avidin-agarose adsorbent for extracorporeal removal of redundant radiopharmaceutical from the blood.
    Kurkus J; Nilsson R; Lindén O; Schönström N; Sandberg BE; Tennvall J
    Artif Organs; 2007 Mar; 31(3):208-14. PubMed ID: 17343696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
    Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.